Clinical Trials Browser

Phase 3 × OTHER × Thoracic Neoplasms × Clear all

Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT03521986 2022-05-11

Pain and Quality of Life After Mediastinal Tumor Resection by Subxiphoid and Intercostal VATS

Phase 3 Unknown

100 enrolled

Thoracic

Mediastinal Neoplasms, Pain, Thoracic Neoplasms

NCT03402048 2020-11-04

EPIC

Phase 3 Unknown

567 enrolled

Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT03331588 2020-03-02

Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung Cancer

Phase 3 Completed

200 enrolled

Thoracic

Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Pain, Thoracic Neoplasms

NCT01024413 2017-03-01

Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations

Phase 3 Completed

256 enrolled

Thoracic

Lung Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

Clinical Trials

NADIM-ADJUVANT

Pain and Quality of Life After Mediastinal Tumor Resection by Subxiphoid and Intercostal VATS

EPIC

Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung Cancer

Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations